Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Clinical trial NCT01091259 · COMPLETED

Trial details

NCT number: NCT01091259
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2010-03-01
Primary completion: 2014-02-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.